These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11443865)

  • 1. EBV's plasmid replicon: an enigma in cis and trans.
    Sugden B; Leight ER
    Curr Top Microbiol Immunol; 2001; 258():3-11. PubMed ID: 11443865
    [No Abstract]   [Full Text] [Related]  

  • 2. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.
    Lindner SE; Sugden B
    Plasmid; 2007 Jul; 58(1):1-12. PubMed ID: 17350094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells.
    Nanbo A; Sugden A; Sugden B
    EMBO J; 2007 Oct; 26(19):4252-62. PubMed ID: 17853891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boundaries of the pSC101 minimal replicon are conditional.
    Miller CA; Ingmer H; Cohen SN
    J Bacteriol; 1995 Sep; 177(17):4865-71. PubMed ID: 7665462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin.
    Dhar SK; Yoshida K; Machida Y; Khaira P; Chaudhuri B; Wohlschlegel JA; Leffak M; Yates J; Dutta A
    Cell; 2001 Aug; 106(3):287-96. PubMed ID: 11509178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of Epstein-Barr virus-derived episomal vectors in the murine Sp2/0 myeloma cell line is dependent upon exogenous expression of human EBP2.
    Habel ME; Drouin M; Jung D
    Biochem Cell Biol; 2004 Jun; 82(3):375-80. PubMed ID: 15181471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes.
    Salamon D; Takacs M; Myöhänen S; Marcsek Z; Berencsi G; Minarovits J
    Biol Chem; 2000 Feb; 381(2):95-105. PubMed ID: 10746740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBNA1 and host factors in Epstein-Barr virus latent DNA replication.
    Frappier L
    Curr Opin Virol; 2012 Dec; 2(6):733-9. PubMed ID: 23031715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].
    Noguchi K
    Yakugaku Zasshi; 2019; 139(1):63-67. PubMed ID: 30606931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.